サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1493095

酵素阻害剤の世界市場規模調査：タイプ別、用途別、地域別予測：2022～2032年

Global Enzyme Inhibitors Market Size study, by Type by Application and Regional Forecasts 2022-2032

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
酵素阻害剤の世界市場規模調査：タイプ別、用途別、地域別予測：2022～2032年
出版日: 2024年06月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

酵素阻害剤の世界市場は、2023年に約1,803億8,000万米ドルとなり、予測期間の2024年から2032年にかけて3.53%以上の健全な成長率で成長すると予測されています。

酵素阻害剤は、酵素の働きを阻害する分子であり、酵素は生体内で生化学反応を促進する役割を担うタンパク質です。これらの阻害剤は酵素に付着し、その活性を一時的または永続的に阻害することができます。酵素阻害剤は、酵素の活性部位を阻害したり、酵素の構造を変化させたり、基質との結合を阻害したりと、様々なメカニズムで機能します。酵素阻害剤は、医学（薬剤として）、農業（殺虫剤として）、生化学（酵素の機能を調べるため）など、いくつかの領域で重要な役割を果たしています。酵素阻害剤は、生物学的プロセスを制御し、病気を治療し、酵素の動態やメカニズムを理解するために使用されます。標的治療と精密医療への注目の高まりは、推定期間中の世界の酵素阻害剤市場の成長を主に支えている主要動向です。酵素阻害剤は、がん、炎症性疾患、代謝障害などの病気に関連する特定の酵素を選択的に標的とし、その活性を制限するもので、製薬会社や研究者によって開発される割合が増加しています。この動向は、創薬、遺伝学、分子生物学の発展により、重要な酵素標的の同定が可能になり、より個別化された効果的な治療法の提供が可能になったことに後押しされています。

外注製造や、がんや呼吸器疾患のような慢性疾患に対する精密で効果的な治療法の開拓により、市場は大幅に拡大しています。また、医薬品開発と承認プロセスの加速を目指した規制の枠組みやイニシアティブが、酵素阻害剤市場への投資と技術革新を後押ししています。これとともに、正確で効率的な医薬品に対する需要の高まり、がんなどの疾患の増加、農業と医薬品における世界の活動の拡大が、酵素阻害剤の世界の需要の主な要因となっています。世界保健機関（WHO）によると、2020年には、世界中で約1,930万人のがん患者が新たに発生したと推定されており、この数は増加し、2040年には3,020万人に達すると予測されています。がんは複雑な多面的疾患であり、様々な生理学的・生化学的変化から生じます。がん細胞はしばしば従来の抗がん剤に対して耐性を獲得し、再発を引き起こします。そのため、新規で強力な抗がん剤の継続的な調査が酵素阻害剤の需要を押し上げ、ひいては市場の成長を促進すると予想されます。しかし、酵素阻害剤の特許切れや、手頃な価格のジェネリック医薬品が入手しやすくなっていることが、2022年から2032年にかけての市場成長を阻害する可能性が高いです。

酵素阻害剤の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、世界のその他の地域です。2023年には、北米が収益面で最大の地域市場となりました。北米市場の拡大は、強固なヘルスケアインフラや有利な償還政策を伴う政府の取り組み強化など、さまざまな要因によって後押しされています。さらに、がんの有病率の増加が同地域の酵素阻害剤市場の成長を促進しています。Canadian Cancer Statistics 2021の報告書によると、カナダでは依然としてがんが主な死因となっています。カナダ人の約5人に2人が一生の間にがんの診断を受け、約4人に1人がこの病気で命を落とすと予測されています。2021年には、推定22万9,200人のカナダ人ががんの診断を受け、約8万4,600人ががん関連死となります。肺がん、乳がん、結腸直腸がん、前立腺がんが引き続き最も多く、2021年には全症例の46％を占めると予想されています。2021年のがん関連死の原因トップ3は、肺がん（25％）、大腸がん（11％）、膵臓がん（7％）と予想されています。その結果、北米におけるがん罹患率の上昇が市場の成長に大きな影響を与えると予想されます。一方、アジア太平洋の市場は、予測期間中に最も速い速度で成長すると予想されています。

目次

第1章 世界の酵素阻害剤市場の定義と調査の前提条件

  • 調査目的
  • 市場の定義
  • 調査の前提条件
    • 包含事項・除外事項
    • 制限事項
    • 供給サイド分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 調査手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブサマリー

  • 酵素阻害剤の世界市場規模・予測（2022～2032年）
  • 地域別概要
  • セグメント別概要
    • タイプ別
    • 用途別
  • 主要動向
  • 景気後退の影響
  • アナリストの結論・提言

第3章 酵素阻害剤の世界市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 酵素阻害剤の世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
    • ポーターのファイブフォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主要な投資機会
  • 主要な成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 酵素阻害剤の世界市場規模・予測：タイプ別、2022～2032年

  • プロトンポンプ阻害薬［PPI］
  • プロテアーゼ阻害剤
  • 逆転写酵素阻害剤
  • キナーゼ阻害剤
  • その他のタイプ

第6章 酵素阻害剤の世界市場規模・予測：用途別、2022～2032年

  • 医療
  • 農業
  • その他の用途

第7章 酵素阻害剤の世界市場規模・予測：地域別、2022～2032年

  • 北米の酵素阻害剤市場
    • 米国
      • タイプの内訳規模・予測、2022～2032年
      • 用途の内訳規模・予測、2022～2032年
    • カナダの酵素阻害剤市場
  • 欧州の酵素阻害剤市場
    • 英国の酵素阻害剤市場
    • ドイツの酵素阻害剤市場
    • フランスの酵素阻害剤市場
    • スペイン酵素阻害剤市場
    • イタリアの酵素阻害剤市場
    • その他欧州の酵素阻害剤市場
  • アジア太平洋の酵素阻害剤市場
    • 中国の酵素阻害剤市場
    • インドの酵素阻害剤市場
    • 日本の酵素阻害剤市場
    • オーストラリアの酵素阻害剤市場
    • 韓国の酵素阻害剤市場
    • その他アジア太平洋の酵素阻害剤市場
  • ラテンアメリカの酵素阻害剤市場
    • ブラジルの酵素阻害剤市場
    • メキシコの酵素阻害剤市場
    • その他ラテンアメリカの酵素阻害剤市場
  • 中東・アフリカの酵素阻害剤市場
    • サウジアラビアの酵素阻害剤市場
    • 南アフリカの酵素阻害剤市場
    • その他中東・アフリカの酵素阻害剤市場

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Abbott Laboratories
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 市場戦略
    • Amgen Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb
    • Cipla Inc.
    • F. Hoffmann-La Roche
    • Novartis AG
    • Pfizer Inc.

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1. Global Enzyme Inhibitors Market, report scope
  • TABLE 2. Global Enzyme Inhibitors Market estimates & forecasts by Region 2022-2032 (USD Billion)
  • TABLE 3. Global Enzyme Inhibitors Market estimates & forecasts by Type 2022-2032 (USD Billion)
  • TABLE 4. Global Enzyme Inhibitors Market estimates & forecasts by Application 2022-2032 (USD Billion)
  • TABLE 5. Global Enzyme Inhibitors Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 6. Global Enzyme Inhibitors Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 7. Global Enzyme Inhibitors Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 8. Global Enzyme Inhibitors Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 9. Global Enzyme Inhibitors Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 10. Global Enzyme Inhibitors Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 11. Global Enzyme Inhibitors Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 12. Global Enzyme Inhibitors Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 13. Global Enzyme Inhibitors Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 14. Global Enzyme Inhibitors Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 15. U.S. Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 16. U.S. Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 17. U.S. Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 18. Canada Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 19. Canada Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 20. Canada Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 21. UK Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 22. UK Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 23. UK Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 24. Germany Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 25. Germany Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 26. Germany Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 27. France Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 28. France Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 29. France Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 30. Italy Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 31. Italy Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 32. Italy Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 33. Spain Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 34. Spain Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 35. Spain Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 36. RoE Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 37. RoE Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 38. RoE Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 39. China Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 40. China Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 41. China Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 42. India Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 43. India Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 44. India Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 45. Japan Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 46. Japan Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 47. Japan Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 48. Australia Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 49. Australia Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 50. Australia Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 51. South Korea Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 52. South Korea Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 53. South Korea Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 54.
  • TABLE 55. RoAPAC Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 56. RoAPAC Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 57. RoAPAC Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 58. Brazil Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 59. Brazil Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 60. Brazil Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 61. Mexico Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 62. Mexico Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 63. Mexico Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 64. RoLA Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 65. RoLA Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 66. RoLA Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 67. Saudi Arabia Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 68. Saudi Arabia Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 69. Saudi Arabia Enzyme Inhibitors Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 70. South Africa Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 71.
  • TABLE 72. South Africa Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 73. South Africa Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 74. RoMEA Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 75. RoMEA Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 76. RoMEA Enzyme Inhibitors Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 77. List of secondary sources, used in the study of Global Enzyme Inhibitors Market.
  • TABLE 78. List of primary sources, used in the study of Global Enzyme Inhibitors Market.
  • TABLE 79. Years considered for the study.
  • TABLE 80. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Enzyme Inhibitors Market, research methodology
  • FIG 2. Global Enzyme Inhibitors Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods.
  • FIG 4. Global Enzyme Inhibitors Market, key trends 2023
  • FIG 5. Global Enzyme Inhibitors Market, growth prospects 2022-2032
  • FIG 6. Global Enzyme Inhibitors Market, porters 5 force model
  • FIG 7. Global Enzyme Inhibitors Market, pestel analysis
  • FIG 8. Global Enzyme Inhibitors Market, value chain analysis
  • FIG 9. Global Enzyme Inhibitors Market by segment, 2022 & 2032 (USD Billion)
  • FIG 10. Global Enzyme Inhibitors Market by segment, 2022 & 2032 (USD Billion)
  • FIG 11. Global Enzyme Inhibitors Market by segment, 2022 & 2032 (USD Billion)
  • FIG 12. Global Enzyme Inhibitors Market by segment, 2022 & 2032 (USD Billion)
  • FIG 13. Global Enzyme Inhibitors Market by segment, 2022 & 2032 (USD Billion)
  • FIG 14. Global Enzyme Inhibitors Market, regional snapshot 2022 & 2032
  • FIG 15. North America Enzyme Inhibitors Market 2022 & 2032 (USD Billion)
  • FIG 16. Europe Enzyme Inhibitors Market 2022 & 2032 (USD Billion)
  • FIG 17. Asia pacific Enzyme Inhibitors Market 2022 & 2032 (USD Billion)
  • FIG 18. Latin America Enzyme Inhibitors Market 2022 & 2032 (USD Billion)
  • FIG 19. Middle East & Africa Enzyme Inhibitors Market 2022 & 2032 (USD Billion)
  • FIG 20. Global Enzyme Inhibitors Market, company market share analysis (2023)
目次

Global Enzyme Inhibitors Market is valued approximately at USD 180.38 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3.53% over the forecast period 2024-2032. Enzyme inhibitors are molecules that impede the function of enzymes, which are proteins responsible for accelerating biochemical reactions in living organisms. These inhibitors can attach to enzymes, disrupting their activity either temporarily or permanently. They function through various mechanisms, such as obstructing the enzyme's active site, changing its structure, or blocking substrate binding. Enzyme inhibitors play crucial roles in several domains, including medicine (as drugs), agriculture (as pesticides), and biochemistry (for investigating enzyme functions). They are used to regulate biological processes, treat diseases, and understand enzyme kinetics and mechanisms. The rising focus on targeted therapies and precision medicine is a key trend that is primarily supporting the growth of the Global Enzyme Inhibitors Market during the estimated period. Enzyme inhibitors, which selectively target and limit the activity of particular enzymes associated with illnesses including cancer, inflammatory disorders, and metabolic problems, have been developed by pharmaceutical firms and researchers at an increasing rate. This trend is fueled by developments in drug discovery, genetics, and molecular biology that make it possible to identify important enzyme targets and provide more individualized and effective therapies.

The market has witnessed a substantial expansion due to outsourced manufacturing and the development of precise and effective treatments for chronic illnesses like cancer and respiratory diseases. Also, supportive regulatory frameworks and initiatives aimed at accelerating drug development and approval processes are encouraging investment and innovation in the enzyme inhibitors market. Along with this, the growing demand for precise and efficient medications, as well as an increase in diseases such as cancer, and the expanding global activities in agriculture and pharmaceuticals are the key factors that are attributing to the demand of enzyme inhibitors globally. According to the World Health Organization, in 2020, it was estimated that nearly 19.3 million new cases of cancer were recorded worldwide, which is projected to rise and is likely to reach 30.2 million new cases by 2040. Cancer is as an intricate multifaceted disease, arises from various physiological and biochemical changes. Cancer cells often develop resistance to traditional anticancer drugs, leading to relapse. Therefore, the continuous research for novel and potent anticancer medications is anticipated to boost the demand for enzyme inhibitors, in turn, propel market growth. However, patent expirations of enzyme inhibitor drugs and the accessibility of affordable generic alternatives are likely to stifle market growth between 2022 and 2032.

The key regions considered for the global Enzyme Inhibitors Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market in terms of revenue. The expansion of the North American market is fueled by various factors, such as a robust healthcare infrastructure and enhanced government initiatives with favorable reimbursement policies. Moreover, the increasing prevalence of cancer is propelling the growth of the enzyme inhibitors market in the region. According to the Canadian Cancer Statistics 2021 report, cancer remains the primary cause of death in Canada. Approximately 2 in 5 Canadians are projected to receive a cancer diagnosis during their lifetime, and about 1 in 4 will succumb to the disease. In 2021, an estimated 229,200 Canadians will receive a cancer diagnosis, leading to approximately 84,600 cancer-related deaths. Lung, breast, colorectal, and prostate cancers are anticipated to remain the most prevalent diagnoses, comprising 46% of all cases in 2021. The top three causes of cancer-related deaths in 2021 are expected to be lung cancer (25%), colorectal cancer (11%), and pancreatic cancer (7%). As a result, the rising incidence of cancer in North America is expected to have a major impact on the growth of the market. Whereas, the market in Asia Pacific, on the other hand, is expected to grow at the fastest rate over the forecast period.

Major market player included in this report are:

  • Abbott Laboratories
  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb
  • Cipla Inc
  • F. Hoffmann-La Roche
  • Novartis AG
  • Pfizer Inc.

The detailed segments and sub-segment of the market are explained below:

By Type

  • Proton Pump Inhibitors [PPIs]
  • Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Kinase Inhibitors
  • Other Types

By Application

  • Medical
  • Agriculture
  • Other Applications

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Enzyme Inhibitors Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global Enzyme Inhibitors Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Type
    • 2.3.2. By Application
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Enzyme Inhibitors Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global Enzyme Inhibitors Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Enzyme Inhibitors Market Size & Forecasts by Type 2022-2032

  • 5.1. Proton Pump Inhibitors [PPIs]
  • 5.2. Protease Inhibitors
  • 5.3. Reverse Transcriptase Inhibitors
  • 5.4. Kinase Inhibitors
  • 5.5. Other Types

Chapter 6. Global Enzyme Inhibitors Market Size & Forecasts by Application 2022-2032

  • 6.1. Medical
  • 6.2. Agriculture
  • 6.3. Other Applications

Chapter 7. Global Enzyme Inhibitors Market Size & Forecasts by Region 2022-2032

  • 7.1. North America Enzyme Inhibitors Market
    • 7.1.1. U.S. Enzyme Inhibitors Market
      • 7.1.1.1. Type breakdown size & forecasts, 2022-2032
      • 7.1.1.2. Application breakdown size & forecasts, 2022-2032
    • 7.1.2. Canada Enzyme Inhibitors Market
  • 7.2. Europe Enzyme Inhibitors Market
    • 7.2.1. U.K. Enzyme Inhibitors Market
    • 7.2.2. Germany Enzyme Inhibitors Market
    • 7.2.3. France Enzyme Inhibitors Market
    • 7.2.4. Spain Enzyme Inhibitors Market
    • 7.2.5. Italy Enzyme Inhibitors Market
    • 7.2.6. Rest of Europe Enzyme Inhibitors Market
  • 7.3. Asia-Pacific Enzyme Inhibitors Market
    • 7.3.1. China Enzyme Inhibitors Market
    • 7.3.2. India Enzyme Inhibitors Market
    • 7.3.3. Japan Enzyme Inhibitors Market
    • 7.3.4. Australia Enzyme Inhibitors Market
    • 7.3.5. South Korea Enzyme Inhibitors Market
    • 7.3.6. Rest of Asia Pacific Enzyme Inhibitors Market
  • 7.4. Latin America Enzyme Inhibitors Market
    • 7.4.1. Brazil Enzyme Inhibitors Market
    • 7.4.2. Mexico Enzyme Inhibitors Market
    • 7.4.3. Rest of Latin America Enzyme Inhibitors Market
  • 7.5. Middle East & Africa Enzyme Inhibitors Market
    • 7.5.1. Saudi Arabia Enzyme Inhibitors Market
    • 7.5.2. South Africa Enzyme Inhibitors Market
    • 7.5.3. Rest of Middle East & Africa Enzyme Inhibitors Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Abbott Laboratories
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. Amgen Inc.
    • 8.3.3. AstraZeneca PLC
    • 8.3.4. Bayer AG
    • 8.3.5. Boehringer Ingelheim International GmbH
    • 8.3.6. Bristol-Myers Squibb
    • 8.3.7. Cipla Inc.
    • 8.3.8. F. Hoffmann-La Roche
    • 8.3.9. Novartis AG
    • 8.3.10. Pfizer Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes